TY  - RPRT
TI  - The immunomodulatory properties of the HDAC6 inhibitor ACY241 supports robust anti-tumor response in NSCLC when coupled with the chemotherapy drug Oxaliplatin
AU  - Bag, A.
AU  - Schultz, A.
AU  - Bhimani, S.
AU  - Dominguez, W.
AU  - Cen, L.
AU  - Adeegbe, D.
PY  - 2021
DO  - 10.1101/2021.10.01.462824
UR  - https://www.biorxiv.org/content/10.1101/2021.10.01.462824v1
ID  - 10.1101/2021.10.01.462824
ER  -